Annual Grant Award Dollars

Investigator Title Sponsor ID Dates Amount
Michael J Absalon, MDPHD Understanding Chemotherapy Failure in AML: Resistance Mechanisms to a Nanoparticle Chemotherapy Delivery System Cancer Free Kids Absalon/Grimes_Cance 12/01/2017 - 11/30/2018 $50,000
Biplab DasGupta, PhD Targeting Tumor Metabolism in Diffuse Intrinsic Pontine Glioma (DIPG) cells. Cancer Free Kids Dasgupta, B, CFK 07/01/2017 - 06/30/2019 $50,000
Biplab DasGupta, PhD Biguanide Sensitivity of Glioma Stem Cells National Institutes of Health R01 NS099162 02/01/2016 - 11/30/2021 $347,104
Biplab DasGupta, PhD Repurposing an FDA-approved Drug for acne to treat Glioblastoma University of Cincinnati MTP Pilot 12/01/2017 - 11/30/2018 $50,000
Biplab DasGupta, PhD Exploring Therapeutic Vulnerability of Passenger Alterations in Glioblastoma University of Cincinnati Cancer Center CCC -Bridge 02/01/2018 - 01/31/2019 $15,000
Peter Matthew Kennedy de Blank, MD Rapid Quantitative MR for Disease Assessment in Pediatric Brain Tumors St. Baldrick's Foundation 527540 07/01/2017 - 06/30/2019 $115,000
Peter Matthew Kennedy de Blank, MD Radiographic Biomarkers and Functional Outcomes of Vision in Optic Pathway Gliomas The Dana Foundation de blank, P., Dana 04/20/2017 - 04/19/2019 $148,118
Rachid Drissi, PhD BMI-1 as a Novel Therapeutic Target to Treat Diffuse Intrinsic Pontine Glioma Cancer Free Kids Drissi, Rachid, CFK 07/01/2017 - 06/30/2019 $50,000
Rachid Drissi, PhD Evaluating the Role of BMI-1 in Diffuse Intrinsic Pontine Glioma Pray Hope Believe Foundation Drissi_PHB Foundation 01/01/2018 - 12/31/2018 $45,614
Maryam Fouladi, MD CONNECT Curing Kids Cancer CKC, Fouladi, Maryam 01/01/2018 - 12/31/2020 $50,000
Maryam Fouladi, MD COG NCTN Network Group Operations Center National Institutes of Health (Children's Hospital of Philadelphia) U10 CA180886 04/11/2014 - 02/28/2019 $7,499
Maryam Fouladi, MD Central Nervous System Tumor Committee National Institutes of Health (Children's Hospital of Philadelphia) U10 CA180886 07/01/2016 - 02/28/2019 $37,500
Maryam Fouladi, MD Pediatric Brain Tumor Consortium (PBTC) National Institutes of Health (St Jude's Children's Hospital) UM1 CA081457 04/01/2014 - 03/31/2019 $94,892
Maryam Fouladi, MD National Institutes of Health (St Jude's Children's Hospital) CA081457 UM1 04/01/2014 - 03/31/2019 $39,000
Maryam Fouladi, MD Establishment of an International Diffuse Intrinsic Pontine Glioma (DIPG) Registry The Cure Starts Now Foundation DIPG - Fouladi 01/01/2012 - 12/31/2018 $233,311
Maryam Fouladi, MD International Collaborative Network for Neurooncology Clinical Trials (CONNECT) The Cure Starts Now Foundation Fouladi, M, CSNF 10/01/2017 - 09/30/2020 $615,162
James Geller, MD NIH COG Phase 1 Study Chair National Institutes of Health (Children's Hospital of Philadelphia) UM1 CA097452 08/01/2012 - 07/31/2018 $7,500
Harry Leighton Grimes, PhD 12th International Workshop on Molecular Aspects of Myeloid Stem Cell Development and Leukemia Taub Foundation Program for MDS Research Grimes, L., Taub 10/01/2017 - 09/30/2018 $40,000
Adrienne Hammill, MD Brain Vascular Malformation Consortium: Predictors of Clinical Course National Institutes of Health (The Regents of the Univ of California) U54 NS065705 09/30/2014 - 07/31/2019 $16,318
Benjamin Mizukawa, MD Precision Medicine in a Pediatric Leukemia Avatar System St. Baldrick's Foundation CDA 07/01/2016 - 06/30/2018 $115,000
Robin E Norris, MD, MPH Evaluating Cdk5 and TGF-ß Inhibitors for the Treatment of Childhood Cancer St. Baldrick's Foundation 422667 08/01/2017 - 06/30/2018 $70,026
Maureen O'Brien, MD Scientific Advisor Board Service Alex's Lemonade Stand Foundation O'Brien, Maureen ALS 12/01/2017 - 11/30/2018 $10,000
Maureen O'Brien, MD T2016-003: Epigenetic Reprogramming in Relapse AML: a Phase I study Children's Hospital Los Angeles T2016003 12/01/2017 - 11/30/2021 $48,001
John P Perentesis, MD COG NCORP Research Base: Per case Reimbursement National Institutes of Health (Children's Hospital of Philadelphia) UG1 CA189955 08/01/2014 - 07/31/2018 $25,000
John P Perentesis, MD CHOP/COG ALTE15N2 LEAHRN (late effects after high-risk Neuroblastoma) St. Baldrick's Foundation (Children's Hospital of Philadelphia) ALTE15N2 03/01/2018 - 02/28/2022 $8,250
Lisa Marie Privette Vinnedge, PhD Exploring the Role of the Oncogene Dek as a Novel Player in Alzheimer’s Disease Life Sciences Research Foundation (University of Cincinnati) life2016 09/01/2016 - 08/31/2018 $18,032
Lisa Marie Privette Vinnedge, PhD Mechanisms Coupling DEK to Oncogenesis National Institutes of Health R01 CA218072 02/08/2018 - 01/31/2023 $363,713
Lisa Marie Privette Vinnedge, PhD Investigating DEK as a prognostic marker for secondary breast cancer in female survivors of pediatric Hodgkin’s Lymphoma University of Cincinnati Cancer Center UCCI2018 03/01/2018 - 02/28/2019 $50,000
Sonya Ruiz-Torres Role of the Fanconi Anemia DNA Repair Pathway in Epidermal Stem and Progenitor Cells and Squamous Cell Carcinoma National Institutes of Health F31 AR070008 09/01/2016 - 08/31/2019 $37,176
Anthony J Sabulski, MD Chemotherapy Treatment in PDX Leukemia Avatars will pressure outgrowth of leukemic clones relevant to patient relapsed or refractory disease American Society of Hematology HONORS 07/01/2017 - 06/30/2018 $5,000
Elizabeth K Schorry, MD DOD Neurofibromatosis Clinical Consortium Award Department of Defense (University of Alabama-Birmingham) W81XWH1720037 08/15/2017 - 08/14/2018 $2,501
Kanimozhi Vairamani, PhD Training Grant (NIEH) National Institutes of Health (University of Cincinnati) 1013581 09/01/2017 - 08/31/2019 $40,180
Brian D Weiss, MD A Phase I/II Study of the Mitogen Activated Protein Kinase (MEK) 1 Inhibitor Selumetinib in Children with Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN) Johns Hopkins School of Medicine 2002883540 01/01/2016 - 12/31/2018 $249,577
Brian D Weiss, MD A Phase I/II Study of the Mitogen Activated Protein Kinase (MEK) 1 Inhibitor Selumetinib in Children with Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN) Johns Hopkins School of Medicine 2001824052 01/01/2016 - 12/31/2018 $137,500
Total Annual Grant Award Dollars $3,191,974

Annual Industry Award Dollars

Investigator Industry Sponsor Amount
Mariko DeWire-Schottmiller, MD Novartis Pharmaceuticals $159,219
Rachid Drissi, PHD PTC Therapeutics, Inc. $61,363
Maryam Fouladi, MD Bristol -Myers Squibb $100,000
Trent Hummel, MD Novartis Pharmaceuticals $47,099
Robin E Norris, MD-MPH AbbVie Inc. $37,587
Robin E Norris, MD-MPH Janssen Research & Development, LLC $91,838
Robin E Norris, MD-MPH Millennium Pharmaceuticals $113,243
Maureen O'Brien, MD AbbVie Inc. $28,180
John P Perentesis, MD Varian Medical Systems, Inc. $1,233,342
Brian D Weiss, MD Ignyta, Inc. $144,383
Maryam Fouladi, MD Novartis Pharmaceuticals (St Jude's Children's Hospital) $21,484
Maryam Fouladi, MD Novocure, Inc (St Jude's Children's Hospital) $16,000
James Geller, MD Eisai Medical Service (Children's Hospital of Philadelphia) $32,384
James Geller, MD Eli Lilly and Company (Children's Hospital of Philadelphia) $6,750
James Geller, MD Pfizer, Inc. (Children's Hospital of Philadelphia) $29,955
Robin E Norris, MD-MPH Bristol -Myers Squibb (Children's Hospital of Philadelphia) $21,700
Maureen O'Brien, MD Celgene Cellular Therapeutics (Children's Hospital of Philadelphia) $40,000
John P Perentesis, MD Bayer HealthCare Pharmaceuticals, Inc. (Children's Hospital of Philadelphia) $16,859
John P Perentesis, MD Eisai, Inc. (Children's Hospital of Philadelphia) $20,000
John P Perentesis, MD Millennium Pharmaceuticals (Children's Hospital of Philadelphia) $14,159
John P Perentesis, MD Pfizer, Inc. (Children's Hospital of Philadelphia) $15,000
Joseph Pressey, MD Merrimack Pharmaceuticals, Inc (Univ of Texas Hlth Science Ctr-Lubbock) $16,500
Brian D Weiss, MD Pfizer, Inc. (Children's Hospital Los Angeles) $14,200
Total Annual Industry Award Dollars $2,281,245